Fresh from a fascinating trip to Interphex 2009 in New York, in-PharmaTechnologist brings you interviews with some of the drug, processing and packaging industry's leading players.
US strategic consultants CourtSquareGroup say that while optimisation of operations is key for the drug industry, companies risk losing the business knowledge required to undertake such action in the scramble to cut costs in the global downturn.
Companies are maintaining their spending on quality control measures despite the challenging operating environment, according to Matthew Kopecky, product manager at Sparta Systems.
The use of intelligent sorbents to improve product stability can save companies six to 12 months of development and boost revenues, according to Adrian Possumato, global director at Multisorb.
PTI’s non-destructive micro leak tester can cut costs for companies using dye ingress, according to general manager Heinz Wolf, who demonstrated the technology to in-PharmaTechnologist at Interphex.
Pall’s Stax single-use depth filter attracted interest from a “number of biotechnology companies” at Interphex, according to director of marketing Ian Sellick who explained how the system can save space, time and money.
Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.
The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.
SGD launched its new lyophilisation vials at Pharmapack 2009, which Vincent Langlade, Marketing Director Pharmaceuticals, explained were well suited to capture the growing market.
Outsourcing-pharma spoke to Amcor Flexibles about the future of the global flexible packaging market.
As the sophistication of counterfeit drug packaging continues to improve it is becoming harder and harder to tell real products from fake. in-PharmaTechnologist spoke with Alpvision's Roland Meylan about the company's approach to brand authentication.
We spoke with Martijn Eijkenboom, president of NAF & VSM, to discuss his companies’ entry into the market for pre-washed vials, ampoules and test tubes.
From emerging market trends to new product launches, this year's CPhI Worldwide in Frankfurt, Germany had something for everyone interested in the drug industry. Our reporting team spoke with all the key players to keep you up to date with all the hot topics.
Reaxa CEO Dr Peter Jackson explains why the firm added a nickel catalyst to its EnCat range.
Cargill discusses its C*PharmDex and Zerose Erythritol excipients at this year's CPhI in Frankfurt, Germany.
SAFC's Mike Harris explains bench top continuous processing at this year's CPhI
Dr Thomas Rosen discusses Cognis' new excipient TPGS, a water soluble form of vitamin E, and its applications in increasing bioavailability.
Tim Bölke, head of the excipient taskforce at the European Fine Chemicals Group, discusses certification and the heparin scandal.
SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.
David Hipkiss explains the benefits for pharmaceutical manufacturers of using Prosonix’ sonocrystallisation technology.